Same Indication

Imatinib vs Levodopa

Imatinib vs Levodopa: Overview

This comparison examines the pharmacological differences between Imatinib and Levodopa.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Levodopa: Metabolic precursor of dopamine that crosses the BBB.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Levodopa — 1.5 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Levodopa — C9H11NO4.

Molecular Weight: Imatinib — 493.6030 g/mol; Levodopa — 197.1880 g/mol.

Type: Imatinib — Small molecule; Levodopa — Small molecule.